MedPath

Olfovel 500mg Tablet

Registration Number: MAL11010021AZ

Approved
Approval ID

05e311bbac743f22

Registration Number

MAL11010021AZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (5)

50 TabletsAvailable
Package Size: 50 Tablets
Status: NPRA Approved
100 TabletsAvailable
Package Size: 100 Tablets
Status: NPRA Approved
500 TabletsAvailable
Package Size: 500 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
300 TabletsAvailable
Package Size: 300 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

LEVOFLOXACIN HEMIHYDRATEActive
Monograph: levofloxacin hemihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Olfovel 500mg Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform